Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 32 entries
Sorted by: Best Match Show Resources per page
The impact of stereotactic radiosurgery in the management of neurofibromatosis type 2-related vestibular schwannomas.

Surgical neurology international

Lustgarten L.
PMID: 23682341
Surg Neurol Int. 2013 Apr 17;4:S151-5. doi: 10.4103/2152-7806.110663. Print 2013.

Although there is an ongoing debate about the ideal management of vestibular schwannomas, radiosurgical treatment has become popular in the past decade with good to excellent results reported. Given the young age at presentation, the bilateral nature of vestibular...

Cite
Lustgarten L. The impact of stereotactic radiosurgery in the management of neurofibromatosis type 2-related vestibular schwannomas. Surg Neurol Int. 2013;4:S151-5doi: 10.4103/2152-7806.110663.
Lustgarten, L. (2013). The impact of stereotactic radiosurgery in the management of neurofibromatosis type 2-related vestibular schwannomas. Surgical neurology international, 4S151-5. https://doi.org/10.4103/2152-7806.110663
Lustgarten, Leonardo. "The impact of stereotactic radiosurgery in the management of neurofibromatosis type 2-related vestibular schwannomas." Surgical neurology international vol. 4 (2013): S151-5. doi: https://doi.org/10.4103/2152-7806.110663
Lustgarten L. The impact of stereotactic radiosurgery in the management of neurofibromatosis type 2-related vestibular schwannomas. Surg Neurol Int. 2013 Apr 17;4:S151-5. doi: 10.4103/2152-7806.110663. Print 2013. PMID: 23682341; PMCID: PMC3654776.
Copy Download .nbib Format: NLM
Structure of the crystalline complex of deoxycytidylyl-3',5'-guanosine (3',5'-dCpdG) cocrystallized with ribonuclease at 1.9 A resolution.

Acta crystallographica. Section D, Biological crystallography

Listgarten JN, Maes D, Wyns L, Aguilar CF, Palmer RA.
PMID: 15299807
Acta Crystallogr D Biol Crystallogr. 1995 Sep 01;51:767-71. doi: 10.1107/S0907444995001570.

The X-ray structure of bovine ribonuclease A cocrystallized with the dinucleotide deoxycytidylyl-3',5'-guanosine has been determined at 1.9 A resolution and refined by restrained least squares to R = 0.218 for 7807 reflections. The structure established that the recently observed...

Cite
Listgarten JN, Maes D, Wyns L, et al. Structure of the crystalline complex of deoxycytidylyl-3',5'-guanosine (3',5'-dCpdG) cocrystallized with ribonuclease at 1.9 A resolution. Acta Crystallogr D Biol Crystallogr. 1995;51:767-71doi: 10.1107/S0907444995001570.
Listgarten, J. N., Maes, D., Wyns, L., Aguilar, C. F., & Palmer, R. A. (1995). Structure of the crystalline complex of deoxycytidylyl-3',5'-guanosine (3',5'-dCpdG) cocrystallized with ribonuclease at 1.9 A resolution. Acta crystallographica. Section D, Biological crystallography, 51767-71. https://doi.org/10.1107/S0907444995001570
Listgarten, J N, et al. "Structure of the crystalline complex of deoxycytidylyl-3',5'-guanosine (3',5'-dCpdG) cocrystallized with ribonuclease at 1.9 A resolution." Acta crystallographica. Section D, Biological crystallography vol. 51 (1995): 767-71. doi: https://doi.org/10.1107/S0907444995001570
Listgarten JN, Maes D, Wyns L, Aguilar CF, Palmer RA. Structure of the crystalline complex of deoxycytidylyl-3',5'-guanosine (3',5'-dCpdG) cocrystallized with ribonuclease at 1.9 A resolution. Acta Crystallogr D Biol Crystallogr. 1995 Sep 01;51:767-71. doi: 10.1107/S0907444995001570. PMID: 15299807.
Copy Download .nbib Format: NLM
PERSONALIZED MEDICINE: FROM GENOTYPES AND MOLECULAR PHENOTYPES TOWARDS COMPUTED THERAPY.

Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing

Stegle O, Brenner SE, Morris Q, Listgarten J.
PMID: 23424122
Pac Symp Biocomput. 2013;18:171-174.

No abstract available.

Cite
Stegle O, Brenner SE, Morris Q, et al. PERSONALIZED MEDICINE: FROM GENOTYPES AND MOLECULAR PHENOTYPES TOWARDS COMPUTED THERAPY. Pac Symp Biocomput. 2013;18:171-174
Stegle, O., Brenner, S. E., Morris, Q., & Listgarten, J. (2013). PERSONALIZED MEDICINE: FROM GENOTYPES AND MOLECULAR PHENOTYPES TOWARDS COMPUTED THERAPY. Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing, 18171-174.
Stegle, Oliver, et al. "PERSONALIZED MEDICINE: FROM GENOTYPES AND MOLECULAR PHENOTYPES TOWARDS COMPUTED THERAPY." Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing vol. 18 (2013): 171-174.
Stegle O, Brenner SE, Morris Q, Listgarten J. PERSONALIZED MEDICINE: FROM GENOTYPES AND MOLECULAR PHENOTYPES TOWARDS COMPUTED THERAPY. Pac Symp Biocomput. 2013;18:171-174. PMID: 23424122; PMCID: PMC5894351.
Copy Download .nbib Format: NLM
Letters to the Editor.

Journal of periodontology

Coatoam GW, Sussman HI, Moss SS, Listgarten MA, Genco RJ, Peros WJ, Greenstein G, Mishkin DJ, Gellin RG.
PMID: 29539804
J Periodontol. 1993 Sep;64(9):917-920. doi: 10.1902/jop.1993.64.9.917.

No abstract available.

Cite
Coatoam GW, Sussman HI, Moss SS, et al. Letters to the Editor. J Periodontol. 1993;64(9):917-920doi: 10.1902/jop.1993.64.9.917.
Coatoam, G. W., Sussman, H. I., Moss, S. S., Listgarten, M. A., Genco, R. J., Peros, W. J., Greenstein, G., Mishkin, D. J., & Gellin, R. G. (1993). Letters to the Editor. Journal of periodontology, 64(9), 917-920. https://doi.org/10.1902/jop.1993.64.9.917
Coatoam, Gary W, et al. "Letters to the Editor." Journal of periodontology vol. 64,9 (1993): 917-920. doi: https://doi.org/10.1902/jop.1993.64.9.917
Coatoam GW, Sussman HI, Moss SS, Listgarten MA, Genco RJ, Peros WJ, Greenstein G, Mishkin DJ, Gellin RG. Letters to the Editor. J Periodontol. 1993 Sep;64(9):917-920. doi: 10.1902/jop.1993.64.9.917. PMID: 29539804.
Copy Download .nbib Format: NLM
Classifying Aging As a Disease: The Role of Microbes.

Frontiers in genetics

Lustgarten MS.
PMID: 27990156
Front Genet. 2016 Dec 01;7:212. doi: 10.3389/fgene.2016.00212. eCollection 2016.

No abstract available.

Cite
Lustgarten MS. Classifying Aging As a Disease: The Role of Microbes. Front Genet. 2016;7:212doi: 10.3389/fgene.2016.00212.
Lustgarten, M. S. (2016). Classifying Aging As a Disease: The Role of Microbes. Frontiers in genetics, 7212. https://doi.org/10.3389/fgene.2016.00212
Lustgarten, Michael S. "Classifying Aging As a Disease: The Role of Microbes." Frontiers in genetics vol. 7 (2016): 212. doi: https://doi.org/10.3389/fgene.2016.00212
Lustgarten MS. Classifying Aging As a Disease: The Role of Microbes. Front Genet. 2016 Dec 01;7:212. doi: 10.3389/fgene.2016.00212. eCollection 2016. PMID: 27990156; PMCID: PMC5130976.
Copy Download .nbib Format: NLM
Letter to the Editors.

Journal of periodontology

Listgarten MA, Saglie R, Holen S.
PMID: 29539670
J Periodontol. 1988 Jun;59(6):412-413. doi: 10.1902/jop.1988.59.6.412.

No abstract available.

Cite
Listgarten MA, Saglie R, Holen S. Letter to the Editors. J Periodontol. 1988;59(6):412-413doi: 10.1902/jop.1988.59.6.412.
Listgarten, M. A., Saglie, R., & Holen, S. (1988). Letter to the Editors. Journal of periodontology, 59(6), 412-413. https://doi.org/10.1902/jop.1988.59.6.412
Listgarten, Max A, et al. "Letter to the Editors." Journal of periodontology vol. 59,6 (1988): 412-413. doi: https://doi.org/10.1902/jop.1988.59.6.412
Listgarten MA, Saglie R, Holen S. Letter to the Editors. J Periodontol. 1988 Jun;59(6):412-413. doi: 10.1902/jop.1988.59.6.412. PMID: 29539670.
Copy Download .nbib Format: NLM
Prediction of off-target activities for the end-to-end design of CRISPR guide RNAs.

Nature biomedical engineering

Listgarten J, Weinstein M, Kleinstiver BP, Sousa AA, Joung JK, Crawford J, Gao K, Hoang L, Elibol M, Doench JG, Fusi N.
PMID: 29998038
Nat Biomed Eng. 2018 Jan;2(1):38-47. doi: 10.1038/s41551-017-0178-6. Epub 2018 Jan 10.

The CRISPR-Cas9 system provides unprecedented genome editing capabilities. However, off-target effects lead to sub-optimal usage and additionally are a bottleneck in the development of therapeutic uses. Herein, we introduce the first machine learning-based approach to off-target prediction, yielding a...

Cite
Listgarten J, Weinstein M, Kleinstiver BP, et al. Prediction of off-target activities for the end-to-end design of CRISPR guide RNAs. Nat Biomed Eng. 2018;2(1):38-47doi: 10.1038/s41551-017-0178-6.
Listgarten, J., Weinstein, M., Kleinstiver, B. P., Sousa, A. A., Joung, J. K., Crawford, J., Gao, K., Hoang, L., Elibol, M., Doench, J. G., & Fusi, N. (2018). Prediction of off-target activities for the end-to-end design of CRISPR guide RNAs. Nature biomedical engineering, 2(1), 38-47. https://doi.org/10.1038/s41551-017-0178-6
Listgarten, Jennifer, et al. "Prediction of off-target activities for the end-to-end design of CRISPR guide RNAs." Nature biomedical engineering vol. 2,1 (2018): 38-47. doi: https://doi.org/10.1038/s41551-017-0178-6
Listgarten J, Weinstein M, Kleinstiver BP, Sousa AA, Joung JK, Crawford J, Gao K, Hoang L, Elibol M, Doench JG, Fusi N. Prediction of off-target activities for the end-to-end design of CRISPR guide RNAs. Nat Biomed Eng. 2018 Jan;2(1):38-47. doi: 10.1038/s41551-017-0178-6. Epub 2018 Jan 10. PMID: 29998038; PMCID: PMC6037314.
Copy Download .nbib Format: NLM
Learning protein fitness models from evolutionary and assay-labeled data.

Nature biotechnology

Hsu C, Nisonoff H, Fannjiang C, Listgarten J.
PMID: 35039677
Nat Biotechnol. 2022 Jan 17; doi: 10.1038/s41587-021-01146-5. Epub 2022 Jan 17.

Machine learning-based models of protein fitness typically learn from either unlabeled, evolutionarily related sequences or variant sequences with experimentally measured labels. For regimes where only limited experimental data are available, recent work has suggested methods for combining both sources...

Cite
Hsu C, Nisonoff H, Fannjiang C, et al. Learning protein fitness models from evolutionary and assay-labeled data. Nat Biotechnol. 2022;doi: 10.1038/s41587-021-01146-5.
Hsu, C., Nisonoff, H., Fannjiang, C., & Listgarten, J. (2022). Learning protein fitness models from evolutionary and assay-labeled data. Nature biotechnology, . https://doi.org/10.1038/s41587-021-01146-5
Hsu, Chloe, et al. "Learning protein fitness models from evolutionary and assay-labeled data." Nature biotechnology vol. (2022). doi: https://doi.org/10.1038/s41587-021-01146-5
Hsu C, Nisonoff H, Fannjiang C, Listgarten J. Learning protein fitness models from evolutionary and assay-labeled data. Nat Biotechnol. 2022 Jan 17; doi: 10.1038/s41587-021-01146-5. Epub 2022 Jan 17. PMID: 35039677.
Copy Download .nbib Format: NLM
In silico insights into potential gut microbial modulation of NAD+ metabolism and longevity.

Journal of biochemical and molecular toxicology

Salekeen R, Siam MHB, Sharif DI, Lustgarten MS, Billah MM, Islam KMD.
PMID: 34580953
J Biochem Mol Toxicol. 2021 Sep 27;e22925. doi: 10.1002/jbt.22925. Epub 2021 Sep 27.

Recent evidence has prompted the notion of gut-microbial signatures as an indirect marker of aging and aging-associated decline in humans. However, the underlying host-symbiont molecular interactions contributing to these signatures remain poorly understood. In this study, we address this...

Cite
Salekeen R, Siam MHB, Sharif DI, et al. In silico insights into potential gut microbial modulation of NAD+ metabolism and longevity. J Biochem Mol Toxicol. 2021;e22925doi: 10.1002/jbt.22925.
Salekeen, R., Siam, M. H. B., Sharif, D. I., Lustgarten, M. S., Billah, M. M., & Islam, K. M. D. (2021). In silico insights into potential gut microbial modulation of NAD+ metabolism and longevity. Journal of biochemical and molecular toxicology, e22925. https://doi.org/10.1002/jbt.22925
Salekeen, Rahagir, et al. "In silico insights into potential gut microbial modulation of NAD+ metabolism and longevity." Journal of biochemical and molecular toxicology vol. (2021): e22925. doi: https://doi.org/10.1002/jbt.22925
Salekeen R, Siam MHB, Sharif DI, Lustgarten MS, Billah MM, Islam KMD. In silico insights into potential gut microbial modulation of NAD+ metabolism and longevity. J Biochem Mol Toxicol. 2021 Sep 27;e22925. doi: 10.1002/jbt.22925. Epub 2021 Sep 27. PMID: 34580953.
Copy Download .nbib Format: NLM
The Use of Oligo Fucoidan in Cancer Bearing Dogs Undergoing Chemotherapy: A Double-Blinded Study.

Topics in companion animal medicine

Post GS, Lustgarten J.
PMID: 34864255
Top Companion Anim Med. 2021 Dec 02;46:100616. doi: 10.1016/j.tcam.2021.100616. Epub 2021 Dec 02.

We evaluated the effect of oligo fucoidan (Laminina Japonica) derived from oceanic brown seaweed on the quality of life in dogs with cancer undergoing chemotherapy in a double-blinded case control study. Included in this prospective study were 100 dogs...

Cite
Post GS, Lustgarten J. The Use of Oligo Fucoidan in Cancer Bearing Dogs Undergoing Chemotherapy: A Double-Blinded Study. Top Companion Anim Med. 2021;46:100616doi: 10.1016/j.tcam.2021.100616.
Post, G. S., & Lustgarten, J. (2021). The Use of Oligo Fucoidan in Cancer Bearing Dogs Undergoing Chemotherapy: A Double-Blinded Study. Topics in companion animal medicine, 46100616. https://doi.org/10.1016/j.tcam.2021.100616
Post, Gerald S, and Lustgarten, Jonathan. "The Use of Oligo Fucoidan in Cancer Bearing Dogs Undergoing Chemotherapy: A Double-Blinded Study." Topics in companion animal medicine vol. 46 (2021): 100616. doi: https://doi.org/10.1016/j.tcam.2021.100616
Post GS, Lustgarten J. The Use of Oligo Fucoidan in Cancer Bearing Dogs Undergoing Chemotherapy: A Double-Blinded Study. Top Companion Anim Med. 2021 Dec 02;46:100616. doi: 10.1016/j.tcam.2021.100616. Epub 2021 Dec 02. PMID: 34864255.
Copy Download .nbib Format: NLM
Bachmann's bundle potential during atrial lead placement: a case series.

Heart rhythm

Infeld M, Habel N, Wahlberg K, Meagher S, Meyer M, Lustgarten D.
PMID: 34775070
Heart Rhythm. 2021 Nov 11; doi: 10.1016/j.hrthm.2021.11.015. Epub 2021 Nov 11.

No abstract available.

Cite
Infeld M, Habel N, Wahlberg K, et al. Bachmann's bundle potential during atrial lead placement: a case series. Heart Rhythm. 2021;doi: 10.1016/j.hrthm.2021.11.015.
Infeld, M., Habel, N., Wahlberg, K., Meagher, S., Meyer, M., & Lustgarten, D. (2021). Bachmann's bundle potential during atrial lead placement: a case series. Heart rhythm, . https://doi.org/10.1016/j.hrthm.2021.11.015
Infeld, Margaret, et al. "Bachmann's bundle potential during atrial lead placement: a case series." Heart rhythm vol. (2021). doi: https://doi.org/10.1016/j.hrthm.2021.11.015
Infeld M, Habel N, Wahlberg K, Meagher S, Meyer M, Lustgarten D. Bachmann's bundle potential during atrial lead placement: a case series. Heart Rhythm. 2021 Nov 11; doi: 10.1016/j.hrthm.2021.11.015. Epub 2021 Nov 11. PMID: 34775070.
Copy Download .nbib Format: NLM
The use of Oligo Fucoidan in Cancer Bearing Dogs Undergoing Chemotherapy: a double-blinded study.

Topics in companion animal medicine

Post GS, Lustgarten J.
PMID: 34864255
Top Companion Anim Med. 2021 Dec 02;100616. doi: 10.1016/j.tcam.2021.100616. Epub 2021 Dec 02.

We evaluated the effect of oligo fucoidan (Laminina Japonica) derived from oceanic brown seaweed on the quality of life in dogs with cancer undergoing chemotherapy in a double-blinded case control study. Included in this prospective study were 100 dogs...

Cite
Post GS, Lustgarten J. The use of Oligo Fucoidan in Cancer Bearing Dogs Undergoing Chemotherapy: a double-blinded study. Top Companion Anim Med. 2021;100616doi: 10.1016/j.tcam.2021.100616.
Post, G. S., & Lustgarten, J. (2021). The use of Oligo Fucoidan in Cancer Bearing Dogs Undergoing Chemotherapy: a double-blinded study. Topics in companion animal medicine, 100616. https://doi.org/10.1016/j.tcam.2021.100616
Post, Gerald S, and Lustgarten, Jonathan. "The use of Oligo Fucoidan in Cancer Bearing Dogs Undergoing Chemotherapy: a double-blinded study." Topics in companion animal medicine vol. (2021): 100616. doi: https://doi.org/10.1016/j.tcam.2021.100616
Post GS, Lustgarten J. The use of Oligo Fucoidan in Cancer Bearing Dogs Undergoing Chemotherapy: a double-blinded study. Top Companion Anim Med. 2021 Dec 02;100616. doi: 10.1016/j.tcam.2021.100616. Epub 2021 Dec 02. PMID: 34864255.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 32 entries